So what is going to happen? We have a range of views from what I can see.
The price is being kept down because some entity wants to buy into the IPO and needs the IPO price to be as low as possible.
OR
The roadshows will cause the bulls to run and new investors will pay a premium for the stock at the time of the IPO.
Which is it? They cannot both be right?
The other thing to consider with regard to HBV. If Biomics which has been working on the project since 2009 thinks that the product is only worth $2.5M at this point in time, what do we think outsiders are going to think of the potential of this pipeline program when it comes to selling the IPO?
BLT Price at posting:
74.0¢ Sentiment: None Disclosure: Held
